Laurion Capital Management’s Elevance Health ELV Stock Holding History

Laurion Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-79,000	Closed	-$21.2M	–	719
2020 Q3	$21.2M	Sell	79,000 -51,200	-39%	-$13.8M	0.25%	96
2020 Q2	$34.2M	Buy	+130,200	New	+$34.7M	0.39%	73
2020 Q1	–	Sell	-31,600	Closed	-$9.54M	–	837
2019 Q4	$9.54M	Buy	+31,600	New	+$8.7M	0.07%	223
2019 Q3	–	Sell	-56,500	Closed	-$15.9M	–	1082
2019 Q2	$15.9M	Buy	56,500 +54,800	+3,224%	+$15M	0.16%	142
2019 Q1	$488K	Buy	1,700 +700	+70%	+$202K	0.01%	636
2018 Q4	$263K	Buy	+1,000	New	+$275K	﹤0.01%	893
2013 Q3	–	Sell	-35,900	Closed	-$2.94M	–	189
2013 Q2	$2.94M	Buy	+35,900	New	+$2.69M	0.18%	91

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Laurion Capital Management's ELV Position: Q3 2025 in Review

Laurion Capital Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 1,550 shares — an estimated $603K sold.

Laurion Capital Management first reported a position in ELV in Q3 2013 and held it in 19 quarters. The position peaked at $32.1M in Q1 2015. 1,511 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Laurion Capital Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Laurion Capital Management sold 1,550 Elevance Health shares in Q3 2025, an estimated $603K.
Laurion Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 19 quarters.
Laurion Capital Management's Elevance Health position peaked at $32.1M in Q1 2015.
1,511 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.